bioAffinity Technologies News

bioAffinity Technologies | DEF 14A: Definitive information statements

Apr 15 06:33 ET

bioAffinity Technologies | DEFA14A: Others

Apr 15 06:29 ET

bioAffinity Technologies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 5 06:12 ET

bioAffinity Technologies | S-1: General form for registration of securities under the Securities Act of 1933

Apr 4 17:11 ET

bioAffinity Technologies | PRE 14A: Preliminary proxy statements relating to merger or acquisition

Apr 2 17:27 ET

bioAffinity Technologies | POS AM: Post-effective amendment to a registration statement that is not immediately effective upon filing

Apr 2 13:12 ET

bioAffinity Technologies | 8-K: bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results

Apr 1 16:04 ET

bioAffinity Technologies | 8-K: Securities Purchase Agreement

Mar 13 16:10 ET

bioAffinity Technologies | 8-K: bioAffinity Technologies Announces Closing of $2.5 Million Registered Direct Offering and Concurrent Private Placement

Mar 8 17:02 ET

bioAffinity Technologies | 8-K: bioAffinity Technologies Reports Accelerating Sales Growth of CyPath® Lung

Mar 5 17:28 ET

bioAffinity Technologies | 8-K: Management Incentive Bonus Plan and Executive Compensation

Jan 31 16:08 ET

bioAffinity Technologies | 8-K: Bioaffinity Technologies Appoints Dr. Jamie Platt as Director and Member of Its Compensation Committee

Dec 5, 2023 08:45 ET

bioAffinity Technologies | 8-K: CMS Posts Final Payment Determination for bioAffinity Technologies' CyPath® Lung Effective January 2024

Nov 30, 2023 09:20 ET

bioAffinity Technologies | S-3: Registration statement for specified transactions by certain issuers

Nov 16, 2023 17:23 ET

bioAffinity Technologies | 8-K: bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update

Nov 15, 2023 17:07 ET

bioAffinity Technologies | 8-K/A: Collection of Recent Announcements

Nov 3, 2023 16:49 ET

bioAffinity Technologies | S-8 POS: S-8 POS

Nov 3, 2023 16:45 ET

bioAffinity Technologies | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

Oct 18, 2023 17:10 ET

bioAffinity Technologies | 8-K: bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference

Oct 10, 2023 17:27 ET

bioAffinity Technologies | S-1: General form for registration of securities under the Securities Act of 1933

Sep 20, 2023 17:29 ET